nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—SLC15A2—multiple sclerosis	0.893	1	CbGaD
Cefuroxime—Ceftibuten—SLC15A2—multiple sclerosis	0.000907	0.117	CrCbGaD
Cefuroxime—Cefazolin—PON1—multiple sclerosis	0.00085	0.109	CrCbGaD
Cefuroxime—Cefepime—SLC15A2—multiple sclerosis	0.000747	0.0961	CrCbGaD
Cefuroxime—Cefixime—SLC15A2—multiple sclerosis	0.000585	0.0752	CrCbGaD
Cefuroxime—Ceftazidime—SLC15A2—multiple sclerosis	0.00055	0.0707	CrCbGaD
Cefuroxime—Cefdinir—SLC15A2—multiple sclerosis	0.00054	0.0694	CrCbGaD
Cefuroxime—Cefaclor—SLC15A2—multiple sclerosis	0.000535	0.0688	CrCbGaD
Cefuroxime—Cefradine—SLC15A2—multiple sclerosis	0.000513	0.0659	CrCbGaD
Cefuroxime—Cefadroxil—SLC15A2—multiple sclerosis	0.000485	0.0623	CrCbGaD
Cefuroxime—Cefotaxime—SLC15A2—multiple sclerosis	0.000423	0.0544	CrCbGaD
Cefuroxime—Ceftriaxone—SLC15A2—multiple sclerosis	0.000417	0.0536	CrCbGaD
Cefuroxime—Cefalotin—SLC15A2—multiple sclerosis	0.000365	0.0469	CrCbGaD
Cefuroxime—Cephalexin—SLC15A2—multiple sclerosis	0.000332	0.0427	CrCbGaD
Cefuroxime—Convulsion—Mitoxantrone—multiple sclerosis	0.000232	0.00234	CcSEcCtD
Cefuroxime—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000231	0.00233	CcSEcCtD
Cefuroxime—Arthralgia—Mitoxantrone—multiple sclerosis	0.000228	0.00229	CcSEcCtD
Cefuroxime—Chest pain—Mitoxantrone—multiple sclerosis	0.000228	0.00229	CcSEcCtD
Cefuroxime—Diarrhoea—Cladribine—multiple sclerosis	0.000227	0.00229	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000221	0.00223	CcSEcCtD
Cefuroxime—Dizziness—Cladribine—multiple sclerosis	0.000219	0.00221	CcSEcCtD
Cefuroxime—Erythema—Prednisolone—multiple sclerosis	0.000219	0.00221	CcSEcCtD
Cefuroxime—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000218	0.0022	CcSEcCtD
Cefuroxime—Neutropenia—Prednisone—multiple sclerosis	0.000214	0.00216	CcSEcCtD
Cefuroxime—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000214	0.00215	CcSEcCtD
Cefuroxime—Abdominal pain—Azathioprine—multiple sclerosis	0.000213	0.00215	CcSEcCtD
Cefuroxime—Body temperature increased—Azathioprine—multiple sclerosis	0.000213	0.00215	CcSEcCtD
Cefuroxime—Tachycardia—Mitoxantrone—multiple sclerosis	0.000213	0.00215	CcSEcCtD
Cefuroxime—Skin disorder—Mitoxantrone—multiple sclerosis	0.000212	0.00214	CcSEcCtD
Cefuroxime—Haemoglobin—Betamethasone—multiple sclerosis	0.000211	0.00213	CcSEcCtD
Cefuroxime—Haemoglobin—Dexamethasone—multiple sclerosis	0.000211	0.00213	CcSEcCtD
Cefuroxime—Irritability—Methotrexate—multiple sclerosis	0.000211	0.00213	CcSEcCtD
Cefuroxime—Vomiting—Cladribine—multiple sclerosis	0.000211	0.00213	CcSEcCtD
Cefuroxime—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000211	0.00213	CcSEcCtD
Cefuroxime—Haemorrhage—Betamethasone—multiple sclerosis	0.00021	0.00212	CcSEcCtD
Cefuroxime—Haemorrhage—Dexamethasone—multiple sclerosis	0.00021	0.00212	CcSEcCtD
Cefuroxime—Angiopathy—Methylprednisolone—multiple sclerosis	0.00021	0.00211	CcSEcCtD
Cefuroxime—Rash—Cladribine—multiple sclerosis	0.000209	0.00211	CcSEcCtD
Cefuroxime—Dermatitis—Cladribine—multiple sclerosis	0.000209	0.00211	CcSEcCtD
Cefuroxime—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000209	0.00211	CcSEcCtD
Cefuroxime—Anorexia—Mitoxantrone—multiple sclerosis	0.000208	0.0021	CcSEcCtD
Cefuroxime—Headache—Cladribine—multiple sclerosis	0.000208	0.0021	CcSEcCtD
Cefuroxime—Erythema—Triamcinolone—multiple sclerosis	0.000202	0.00203	CcSEcCtD
Cefuroxime—Erythema—Methylprednisolone—multiple sclerosis	0.000201	0.00203	CcSEcCtD
Cefuroxime—Angioedema—Prednisolone—multiple sclerosis	0.0002	0.00202	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000199	0.00201	CcSEcCtD
Cefuroxime—Hypersensitivity—Azathioprine—multiple sclerosis	0.000199	0.00201	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000199	0.002	CcSEcCtD
Cefuroxime—Nausea—Cladribine—multiple sclerosis	0.000197	0.00199	CcSEcCtD
Cefuroxime—Cefonicid—ALB—multiple sclerosis	0.000195	0.0251	CrCbGaD
Cefuroxime—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000194	0.00196	CcSEcCtD
Cefuroxime—Somnolence—Mitoxantrone—multiple sclerosis	0.000194	0.00196	CcSEcCtD
Cefuroxime—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000192	0.00194	CcSEcCtD
Cefuroxime—Angiopathy—Dexamethasone—multiple sclerosis	0.000191	0.00192	CcSEcCtD
Cefuroxime—Angiopathy—Betamethasone—multiple sclerosis	0.000191	0.00192	CcSEcCtD
Cefuroxime—Convulsion—Prednisolone—multiple sclerosis	0.00019	0.00192	CcSEcCtD
Cefuroxime—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00019	0.00191	CcSEcCtD
Cefuroxime—Eosinophilia—Methotrexate—multiple sclerosis	0.000189	0.00191	CcSEcCtD
Cefuroxime—Pain—Mitoxantrone—multiple sclerosis	0.000187	0.00188	CcSEcCtD
Cefuroxime—Diarrhoea—Azathioprine—multiple sclerosis	0.000185	0.00186	CcSEcCtD
Cefuroxime—Angioedema—Triamcinolone—multiple sclerosis	0.000184	0.00186	CcSEcCtD
Cefuroxime—Haemoglobin—Prednisone—multiple sclerosis	0.000184	0.00186	CcSEcCtD
Cefuroxime—Angioedema—Methylprednisolone—multiple sclerosis	0.000184	0.00185	CcSEcCtD
Cefuroxime—Haemorrhage—Prednisone—multiple sclerosis	0.000183	0.00185	CcSEcCtD
Cefuroxime—Erythema—Betamethasone—multiple sclerosis	0.000183	0.00185	CcSEcCtD
Cefuroxime—Erythema—Dexamethasone—multiple sclerosis	0.000183	0.00185	CcSEcCtD
Cefuroxime—Pancytopenia—Methotrexate—multiple sclerosis	0.000182	0.00183	CcSEcCtD
Cefuroxime—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000179	0.0018	CcSEcCtD
Cefuroxime—Neutropenia—Methotrexate—multiple sclerosis	0.000179	0.0018	CcSEcCtD
Cefuroxime—Dysuria—Methotrexate—multiple sclerosis	0.000179	0.0018	CcSEcCtD
Cefuroxime—Dizziness—Azathioprine—multiple sclerosis	0.000178	0.0018	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000178	0.0018	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000178	0.00179	CcSEcCtD
Cefuroxime—Cough—Triamcinolone—multiple sclerosis	0.000176	0.00177	CcSEcCtD
Cefuroxime—Convulsion—Triamcinolone—multiple sclerosis	0.000175	0.00176	CcSEcCtD
Cefuroxime—Tachycardia—Prednisolone—multiple sclerosis	0.000175	0.00176	CcSEcCtD
Cefuroxime—Convulsion—Methylprednisolone—multiple sclerosis	0.000174	0.00176	CcSEcCtD
Cefuroxime—Urticaria—Mitoxantrone—multiple sclerosis	0.000173	0.00175	CcSEcCtD
Cefuroxime—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000173	0.00174	CcSEcCtD
Cefuroxime—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000172	0.00174	CcSEcCtD
Cefuroxime—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000172	0.00174	CcSEcCtD
Cefuroxime—Vomiting—Azathioprine—multiple sclerosis	0.000172	0.00173	CcSEcCtD
Cefuroxime—Arthralgia—Methylprednisolone—multiple sclerosis	0.000171	0.00173	CcSEcCtD
Cefuroxime—Infestation—Methotrexate—multiple sclerosis	0.00017	0.00172	CcSEcCtD
Cefuroxime—Infestation NOS—Methotrexate—multiple sclerosis	0.00017	0.00172	CcSEcCtD
Cefuroxime—Drowsiness—Methotrexate—multiple sclerosis	0.00017	0.00172	CcSEcCtD
Cefuroxime—Rash—Azathioprine—multiple sclerosis	0.00017	0.00172	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00017	0.00172	CcSEcCtD
Cefuroxime—Dermatitis—Azathioprine—multiple sclerosis	0.00017	0.00171	CcSEcCtD
Cefuroxime—Headache—Azathioprine—multiple sclerosis	0.000169	0.0017	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000169	0.0017	CcSEcCtD
Cefuroxime—Renal failure—Methotrexate—multiple sclerosis	0.000168	0.00169	CcSEcCtD
Cefuroxime—Angioedema—Dexamethasone—multiple sclerosis	0.000167	0.00169	CcSEcCtD
Cefuroxime—Angioedema—Betamethasone—multiple sclerosis	0.000167	0.00169	CcSEcCtD
Cefuroxime—Stomatitis—Methotrexate—multiple sclerosis	0.000166	0.00168	CcSEcCtD
Cefuroxime—Angiopathy—Prednisone—multiple sclerosis	0.000166	0.00167	CcSEcCtD
Cefuroxime—Immune system disorder—Prednisone—multiple sclerosis	0.000165	0.00167	CcSEcCtD
Cefuroxime—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000165	0.00166	CcSEcCtD
Cefuroxime—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000164	0.00166	CcSEcCtD
Cefuroxime—Sweating—Methotrexate—multiple sclerosis	0.000163	0.00165	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000161	0.00163	CcSEcCtD
Cefuroxime—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000161	0.00162	CcSEcCtD
Cefuroxime—Tachycardia—Triamcinolone—multiple sclerosis	0.000161	0.00162	CcSEcCtD
Cefuroxime—Nausea—Azathioprine—multiple sclerosis	0.00016	0.00162	CcSEcCtD
Cefuroxime—Tachycardia—Methylprednisolone—multiple sclerosis	0.00016	0.00162	CcSEcCtD
Cefuroxime—Skin disorder—Methylprednisolone—multiple sclerosis	0.00016	0.00161	CcSEcCtD
Cefuroxime—Erythema—Prednisone—multiple sclerosis	0.000159	0.00161	CcSEcCtD
Cefuroxime—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000159	0.0016	CcSEcCtD
Cefuroxime—Agranulocytosis—Methotrexate—multiple sclerosis	0.000159	0.0016	CcSEcCtD
Cefuroxime—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000159	0.0016	CcSEcCtD
Cefuroxime—Convulsion—Betamethasone—multiple sclerosis	0.000159	0.0016	CcSEcCtD
Cefuroxime—Convulsion—Dexamethasone—multiple sclerosis	0.000159	0.0016	CcSEcCtD
Cefuroxime—Haemoglobin—Methotrexate—multiple sclerosis	0.000154	0.00155	CcSEcCtD
Cefuroxime—Pain—Prednisolone—multiple sclerosis	0.000153	0.00154	CcSEcCtD
Cefuroxime—Hepatitis—Methotrexate—multiple sclerosis	0.000153	0.00154	CcSEcCtD
Cefuroxime—Haemorrhage—Methotrexate—multiple sclerosis	0.000153	0.00154	CcSEcCtD
Cefuroxime—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000151	0.00152	CcSEcCtD
Cefuroxime—Urethral disorder—Methotrexate—multiple sclerosis	0.00015	0.00151	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00015	0.00151	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00015	0.00151	CcSEcCtD
Cefuroxime—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000149	0.00151	CcSEcCtD
Cefuroxime—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000149	0.00151	CcSEcCtD
Cefuroxime—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000149	0.00151	CcSEcCtD
Cefuroxime—Dyspnoea—Triamcinolone—multiple sclerosis	0.000147	0.00148	CcSEcCtD
Cefuroxime—Agitation—Prednisone—multiple sclerosis	0.000146	0.00148	CcSEcCtD
Cefuroxime—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000146	0.00147	CcSEcCtD
Cefuroxime—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000146	0.00147	CcSEcCtD
Cefuroxime—Tachycardia—Betamethasone—multiple sclerosis	0.000146	0.00147	CcSEcCtD
Cefuroxime—Tachycardia—Dexamethasone—multiple sclerosis	0.000146	0.00147	CcSEcCtD
Cefuroxime—Angioedema—Prednisone—multiple sclerosis	0.000146	0.00147	CcSEcCtD
Cefuroxime—Dyspepsia—Triamcinolone—multiple sclerosis	0.000145	0.00146	CcSEcCtD
Cefuroxime—Erythema multiforme—Methotrexate—multiple sclerosis	0.000145	0.00146	CcSEcCtD
Cefuroxime—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000145	0.00146	CcSEcCtD
Cefuroxime—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000144	0.00146	CcSEcCtD
Cefuroxime—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000144	0.00146	CcSEcCtD
Cefuroxime—Anorexia—Betamethasone—multiple sclerosis	0.000142	0.00144	CcSEcCtD
Cefuroxime—Anorexia—Dexamethasone—multiple sclerosis	0.000142	0.00144	CcSEcCtD
Cefuroxime—Urticaria—Prednisolone—multiple sclerosis	0.000142	0.00143	CcSEcCtD
Cefuroxime—Pain—Triamcinolone—multiple sclerosis	0.000141	0.00142	CcSEcCtD
Cefuroxime—Angiopathy—Methotrexate—multiple sclerosis	0.000139	0.0014	CcSEcCtD
Cefuroxime—Vomiting—Mitoxantrone—multiple sclerosis	0.000139	0.0014	CcSEcCtD
Cefuroxime—Immune system disorder—Methotrexate—multiple sclerosis	0.000138	0.00139	CcSEcCtD
Cefuroxime—Convulsion—Prednisone—multiple sclerosis	0.000138	0.00139	CcSEcCtD
Cefuroxime—Rash—Mitoxantrone—multiple sclerosis	0.000138	0.00139	CcSEcCtD
Cefuroxime—Dermatitis—Mitoxantrone—multiple sclerosis	0.000137	0.00139	CcSEcCtD
Cefuroxime—Chills—Methotrexate—multiple sclerosis	0.000137	0.00138	CcSEcCtD
Cefuroxime—Headache—Mitoxantrone—multiple sclerosis	0.000137	0.00138	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000136	0.00137	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000136	0.00137	CcSEcCtD
Cefuroxime—Arthralgia—Prednisone—multiple sclerosis	0.000136	0.00137	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000135	0.00136	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000134	0.00135	CcSEcCtD
Cefuroxime—Erythema—Methotrexate—multiple sclerosis	0.000133	0.00134	CcSEcCtD
Cefuroxime—Hypersensitivity—Prednisolone—multiple sclerosis	0.000132	0.00133	CcSEcCtD
Cefuroxime—Dyspepsia—Dexamethasone—multiple sclerosis	0.000131	0.00133	CcSEcCtD
Cefuroxime—Dyspepsia—Betamethasone—multiple sclerosis	0.000131	0.00133	CcSEcCtD
Cefuroxime—Urticaria—Triamcinolone—multiple sclerosis	0.000131	0.00132	CcSEcCtD
Cefuroxime—Urticaria—Methylprednisolone—multiple sclerosis	0.00013	0.00132	CcSEcCtD
Cefuroxime—Body temperature increased—Triamcinolone—multiple sclerosis	0.00013	0.00131	CcSEcCtD
Cefuroxime—Anaphylactic shock—Prednisone—multiple sclerosis	0.00013	0.00131	CcSEcCtD
Cefuroxime—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00013	0.00131	CcSEcCtD
Cefuroxime—Decreased appetite—Dexamethasone—multiple sclerosis	0.00013	0.00131	CcSEcCtD
Cefuroxime—Decreased appetite—Betamethasone—multiple sclerosis	0.00013	0.00131	CcSEcCtD
Cefuroxime—Nausea—Mitoxantrone—multiple sclerosis	0.00013	0.00131	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000129	0.0013	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000129	0.0013	CcSEcCtD
Cefuroxime—Pain—Dexamethasone—multiple sclerosis	0.000128	0.00129	CcSEcCtD
Cefuroxime—Pain—Betamethasone—multiple sclerosis	0.000128	0.00129	CcSEcCtD
Cefuroxime—Tachycardia—Prednisone—multiple sclerosis	0.000127	0.00128	CcSEcCtD
Cefuroxime—Skin disorder—Prednisone—multiple sclerosis	0.000126	0.00127	CcSEcCtD
Cefuroxime—Hyperhidrosis—Prednisone—multiple sclerosis	0.000126	0.00127	CcSEcCtD
Cefuroxime—Anorexia—Prednisone—multiple sclerosis	0.000124	0.00125	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000122	0.00123	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000122	0.00123	CcSEcCtD
Cefuroxime—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000121	0.00122	CcSEcCtD
Cefuroxime—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000121	0.00122	CcSEcCtD
Cefuroxime—Leukopenia—Methotrexate—multiple sclerosis	0.000119	0.0012	CcSEcCtD
Cefuroxime—Urticaria—Dexamethasone—multiple sclerosis	0.000119	0.0012	CcSEcCtD
Cefuroxime—Urticaria—Betamethasone—multiple sclerosis	0.000119	0.0012	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000118	0.00119	CcSEcCtD
Cefuroxime—Dizziness—Prednisolone—multiple sclerosis	0.000118	0.00119	CcSEcCtD
Cefuroxime—Abdominal pain—Dexamethasone—multiple sclerosis	0.000118	0.00119	CcSEcCtD
Cefuroxime—Abdominal pain—Betamethasone—multiple sclerosis	0.000118	0.00119	CcSEcCtD
Cefuroxime—Body temperature increased—Dexamethasone—multiple sclerosis	0.000118	0.00119	CcSEcCtD
Cefuroxime—Body temperature increased—Betamethasone—multiple sclerosis	0.000118	0.00119	CcSEcCtD
Cefuroxime—Pruritus—Triamcinolone—multiple sclerosis	0.000116	0.00117	CcSEcCtD
Cefuroxime—Cough—Methotrexate—multiple sclerosis	0.000116	0.00117	CcSEcCtD
Cefuroxime—Pruritus—Methylprednisolone—multiple sclerosis	0.000116	0.00117	CcSEcCtD
Cefuroxime—Convulsion—Methotrexate—multiple sclerosis	0.000115	0.00116	CcSEcCtD
Cefuroxime—Dyspepsia—Prednisone—multiple sclerosis	0.000114	0.00115	CcSEcCtD
Cefuroxime—Chest pain—Methotrexate—multiple sclerosis	0.000113	0.00114	CcSEcCtD
Cefuroxime—Arthralgia—Methotrexate—multiple sclerosis	0.000113	0.00114	CcSEcCtD
Cefuroxime—Decreased appetite—Prednisone—multiple sclerosis	0.000113	0.00114	CcSEcCtD
Cefuroxime—Rash—Prednisolone—multiple sclerosis	0.000113	0.00114	CcSEcCtD
Cefuroxime—Dermatitis—Prednisolone—multiple sclerosis	0.000113	0.00114	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000113	0.00114	CcSEcCtD
Cefuroxime—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000112	0.00113	CcSEcCtD
Cefuroxime—Headache—Prednisolone—multiple sclerosis	0.000112	0.00113	CcSEcCtD
Cefuroxime—Dizziness—Triamcinolone—multiple sclerosis	0.000109	0.0011	CcSEcCtD
Cefuroxime—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000109	0.0011	CcSEcCtD
Cefuroxime—Dizziness—Methylprednisolone—multiple sclerosis	0.000109	0.0011	CcSEcCtD
Cefuroxime—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000106	0.00107	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000106	0.00107	CcSEcCtD
Cefuroxime—Nausea—Prednisolone—multiple sclerosis	0.000106	0.00107	CcSEcCtD
Cefuroxime—Pruritus—Betamethasone—multiple sclerosis	0.000106	0.00107	CcSEcCtD
Cefuroxime—Pruritus—Dexamethasone—multiple sclerosis	0.000106	0.00107	CcSEcCtD
Cefuroxime—Skin disorder—Methotrexate—multiple sclerosis	0.000106	0.00106	CcSEcCtD
Cefuroxime—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000105	0.00106	CcSEcCtD
Cefuroxime—Vomiting—Triamcinolone—multiple sclerosis	0.000105	0.00106	CcSEcCtD
Cefuroxime—Vomiting—Methylprednisolone—multiple sclerosis	0.000104	0.00105	CcSEcCtD
Cefuroxime—Rash—Triamcinolone—multiple sclerosis	0.000104	0.00105	CcSEcCtD
Cefuroxime—Dermatitis—Triamcinolone—multiple sclerosis	0.000104	0.00105	CcSEcCtD
Cefuroxime—Anorexia—Methotrexate—multiple sclerosis	0.000104	0.00104	CcSEcCtD
Cefuroxime—Rash—Methylprednisolone—multiple sclerosis	0.000104	0.00104	CcSEcCtD
Cefuroxime—Dermatitis—Methylprednisolone—multiple sclerosis	0.000103	0.00104	CcSEcCtD
Cefuroxime—Urticaria—Prednisone—multiple sclerosis	0.000103	0.00104	CcSEcCtD
Cefuroxime—Headache—Triamcinolone—multiple sclerosis	0.000103	0.00104	CcSEcCtD
Cefuroxime—Headache—Methylprednisolone—multiple sclerosis	0.000103	0.00104	CcSEcCtD
Cefuroxime—Body temperature increased—Prednisone—multiple sclerosis	0.000103	0.00104	CcSEcCtD
Cefuroxime—Abdominal pain—Prednisone—multiple sclerosis	0.000103	0.00104	CcSEcCtD
Cefuroxime—Diarrhoea—Betamethasone—multiple sclerosis	0.000102	0.00103	CcSEcCtD
Cefuroxime—Diarrhoea—Dexamethasone—multiple sclerosis	0.000102	0.00103	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9.9e-05	0.000999	CcSEcCtD
Cefuroxime—Dizziness—Dexamethasone—multiple sclerosis	9.88e-05	0.000996	CcSEcCtD
Cefuroxime—Dizziness—Betamethasone—multiple sclerosis	9.88e-05	0.000996	CcSEcCtD
Cefuroxime—Nausea—Triamcinolone—multiple sclerosis	9.78e-05	0.000986	CcSEcCtD
Cefuroxime—Nausea—Methylprednisolone—multiple sclerosis	9.75e-05	0.000984	CcSEcCtD
Cefuroxime—Dyspnoea—Methotrexate—multiple sclerosis	9.69e-05	0.000977	CcSEcCtD
Cefuroxime—Somnolence—Methotrexate—multiple sclerosis	9.66e-05	0.000974	CcSEcCtD
Cefuroxime—Hypersensitivity—Prednisone—multiple sclerosis	9.58e-05	0.000966	CcSEcCtD
Cefuroxime—Dyspepsia—Methotrexate—multiple sclerosis	9.57e-05	0.000965	CcSEcCtD
Cefuroxime—Vomiting—Dexamethasone—multiple sclerosis	9.49e-05	0.000958	CcSEcCtD
Cefuroxime—Vomiting—Betamethasone—multiple sclerosis	9.49e-05	0.000958	CcSEcCtD
Cefuroxime—Cefazolin—ALB—multiple sclerosis	9.46e-05	0.0122	CrCbGaD
Cefuroxime—Decreased appetite—Methotrexate—multiple sclerosis	9.45e-05	0.000953	CcSEcCtD
Cefuroxime—Rash—Dexamethasone—multiple sclerosis	9.42e-05	0.00095	CcSEcCtD
Cefuroxime—Rash—Betamethasone—multiple sclerosis	9.42e-05	0.00095	CcSEcCtD
Cefuroxime—Dermatitis—Dexamethasone—multiple sclerosis	9.41e-05	0.000949	CcSEcCtD
Cefuroxime—Dermatitis—Betamethasone—multiple sclerosis	9.41e-05	0.000949	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.38e-05	0.000946	CcSEcCtD
Cefuroxime—Headache—Betamethasone—multiple sclerosis	9.36e-05	0.000943	CcSEcCtD
Cefuroxime—Headache—Dexamethasone—multiple sclerosis	9.36e-05	0.000943	CcSEcCtD
Cefuroxime—Pain—Methotrexate—multiple sclerosis	9.29e-05	0.000937	CcSEcCtD
Cefuroxime—Pruritus—Prednisone—multiple sclerosis	9.2e-05	0.000928	CcSEcCtD
Cefuroxime—Ceftriaxone—ALB—multiple sclerosis	8.97e-05	0.0115	CrCbGaD
Cefuroxime—Diarrhoea—Prednisone—multiple sclerosis	8.9e-05	0.000897	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.89e-05	0.000896	CcSEcCtD
Cefuroxime—Nausea—Betamethasone—multiple sclerosis	8.87e-05	0.000895	CcSEcCtD
Cefuroxime—Nausea—Dexamethasone—multiple sclerosis	8.87e-05	0.000895	CcSEcCtD
Cefuroxime—Urticaria—Methotrexate—multiple sclerosis	8.63e-05	0.000871	CcSEcCtD
Cefuroxime—Dizziness—Prednisone—multiple sclerosis	8.6e-05	0.000867	CcSEcCtD
Cefuroxime—Abdominal pain—Methotrexate—multiple sclerosis	8.59e-05	0.000867	CcSEcCtD
Cefuroxime—Body temperature increased—Methotrexate—multiple sclerosis	8.59e-05	0.000867	CcSEcCtD
Cefuroxime—Vomiting—Prednisone—multiple sclerosis	8.27e-05	0.000834	CcSEcCtD
Cefuroxime—Rash—Prednisone—multiple sclerosis	8.2e-05	0.000827	CcSEcCtD
Cefuroxime—Dermatitis—Prednisone—multiple sclerosis	8.19e-05	0.000826	CcSEcCtD
Cefuroxime—Headache—Prednisone—multiple sclerosis	8.15e-05	0.000822	CcSEcCtD
Cefuroxime—Hypersensitivity—Methotrexate—multiple sclerosis	8.01e-05	0.000808	CcSEcCtD
Cefuroxime—Cefalotin—ALB—multiple sclerosis	7.85e-05	0.0101	CrCbGaD
Cefuroxime—Nausea—Prednisone—multiple sclerosis	7.72e-05	0.000779	CcSEcCtD
Cefuroxime—Pruritus—Methotrexate—multiple sclerosis	7.69e-05	0.000776	CcSEcCtD
Cefuroxime—Diarrhoea—Methotrexate—multiple sclerosis	7.44e-05	0.00075	CcSEcCtD
Cefuroxime—Dizziness—Methotrexate—multiple sclerosis	7.19e-05	0.000725	CcSEcCtD
Cefuroxime—Cephalexin—ALB—multiple sclerosis	7.14e-05	0.00918	CrCbGaD
Cefuroxime—Vomiting—Methotrexate—multiple sclerosis	6.91e-05	0.000697	CcSEcCtD
Cefuroxime—Rash—Methotrexate—multiple sclerosis	6.85e-05	0.000691	CcSEcCtD
Cefuroxime—Dermatitis—Methotrexate—multiple sclerosis	6.85e-05	0.00069	CcSEcCtD
Cefuroxime—Headache—Methotrexate—multiple sclerosis	6.81e-05	0.000687	CcSEcCtD
Cefuroxime—Nausea—Methotrexate—multiple sclerosis	6.46e-05	0.000651	CcSEcCtD
